Mulmit

Upstream Bio, Inc.Upstream Bio, Inc.

UPB Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-312,854,000-160,361,000-143,443,000-2.66
2024-12-312,370,000-77,764,000-62,806,000-5.58
2023-12-312,380,000-40,114,000-20,537,000-12.95

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-16Deykin AaronChief Medical Officer895
2026-09-16Sutherland Everett RandChief Executive Officer2,095
2026-09-16Houghton AdamChief Business Officer700
2026-09-16GRAY MICHAELCFO and COO853
2026-09-16Ambrose AllisonGeneral Counsel485
2026-06-16GRAY MICHAELCFO and COO853
2026-06-16Sutherland Everett RandChief Executive Officer2,095
2026-06-16Houghton AdamChief Business Officer700
2026-06-16Deykin AaronChief Medical Officer895
2026-06-16Ambrose AllisonGeneral Counsel477
2026-06-09Ruddy Marcella K.17,096
2026-06-09Renaud Ronald C JR17,096

8-K events

FiledItems
2026-09-01Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-11Results of operations · Financial statements and exhibits
2026-06-10Submission of matters to a vote
2026-05-13Results of operations · Financial statements and exhibits
2026-03-26Entry into a material agreement · Financial statements and exhibits
2026-03-26Results of operations · Financial statements and exhibits
2026-02-11Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-02-11Regulation FD disclosure · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.